back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-12-13 Tx date 2018-12-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-1,644 vol |
6,550 | |
| Filed 2018-12-13 Tx date 2018-12-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,390.10
-4,115 vol $3.74 each |
160,915 | |
| Filed 2018-12-13 Tx date 2018-12-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,390
+4,115 vol $3.74 each |
8,194 | |
| Filed 2018-03-13 Tx date 2018-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
165,030 | |
| Filed 2018-02-14 Tx date 2018-02-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-22,669 vol |
129,109 | |
| Filed 2018-02-14 Tx date 2014-11-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-14 Tx date 2018-02-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,255
+4,079 vol $3.74 each |
4,079 | |
| Filed 2018-02-14 Tx date 2018-02-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-4,079 vol |
125,030 | |
| Filed 2017-10-24 Tx date 2017-10-23 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,000 vol |
151,778 | |
| Filed 2017-03-14 Tx date 2017-03-13 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
140,778 | |
| Filed 2016-03-11 Tx date 2016-03-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
120,778 | |
| Filed 2015-12-21 Tx date 2015-12-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Cohen, Charles Jay
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
95,778 |